Kyprolis (carfilzomib) 60 mg, solution for infusion, original (Amgen) Targeted cancer therapy. Drug delivery from Europe within 4-5 days, guaranteed storage conditions, payment upon receipt. Order by calling +380996042415, Viber, or WhatsApp.

Indications for use

Carfilzomib is indicated for the treatment of adult patients with relapsed or refractory multiple myeloma who have received one to three prior lines of therapy in combination with lenalidomide and dexamethasone; or dexamethasone; or daratumumab and dexamethasone; or daratumumab and hyaluronidase-fihj and dexamethasone; or isatuximab and dexamethasone. It is also indicated as monotherapy for the treatment of patients with relapsed or refractory multiple myeloma who have received one or more prior lines of therapy.